Intelligence Platform

Patents

Browse 400 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7833533

Enhanced antiviral activity against foot and mouth disease

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7820181

Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of reco

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7803386

Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7794734

Mannheimia haemolytica chimeric outer membrane protein PlpE and leukotoxin epitopes as a v

The Board of Regents for Oklahoma State University · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7790182

Protein vaccines against poxviruses

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7786285

Recombinant vaccine against botulinum neurotoxin

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7763716

Antibody against NPW

Takeda Pharmaceutical Company Limited · Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7754227

Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7737256

Antibody against uPA/uPAR

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7704509

Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of reco

The United States of America · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7700578

Capsule composition for use as immunogen against Campylobacter jejuni

United States of America as represented by the Secretary of the Air Force · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7666846

Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662395

Method of enhancing a targeted immune response against tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655241

Methods and compositions for vaccination against or involving enterobacteriaceae bacteria

The Board of Regents of the University of Texas System · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655762

Monoclonal antibodies against ANGPTL4

LEXICON PHARMACEUTICALS, INC. · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655694

Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7635485

Method of accelerated vaccination against Ebola viruses

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7618616

Skin-protective compositions effective against vesicants and percutaneous chemical agents

State of Israel, Prime Minister's Office, Israel Insitute For Biological Research · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7604811

Oral-intestinal vaccines against diseases caused by enteropathic organisms using antigens

The United States of America as represented by the Secretary of the Army · Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7601735

Antiviral compounds

Airgain, Inc. · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582662

Body weight gain inhibitor

Takeda Pharmaceutical Company Limited · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572449

Vaccine against Yersinia comprising one or two antibodies, one specific for Yersinia pesti

The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572891

Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

The Regents of the University of California · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566552

Protection against environmental toxicity through manipulation of the processing of messen

CropDesign N.V. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted